A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis

Journal of Hepatology

Volumn 34, Issue 2, 2001, Pages 292-298

  Hay, J Eileen ^a   Malinchoc, Michael ^a   Dickson, E Rolland ^a  

^a MAYO CLINIC   (United States)

Author keywords

Calcitonin therapy; Cholestatic osteopenia; Posttransplant osteopenia

Indexed keywords

SALCATONIN;

ADULT; ARTICLE; BILIARY CIRRHOSIS; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE PAIN; BONE RADIOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS;

ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; BONE RESORPTION; CALCITONIN; CHOLANGITIS, SCLEROSING; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0035113901     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)00093-3     Document Type: Article

References (39)

1. Bone disease in cholestatic liver disease
2. The metatolobic bone disease of primary sclerosing cholangitis
3. Osteoporosis in chronic cholestatic liver disease
4. Lack of osteomalacia in chronic cholestatic liver disease
5. Bone loss and reduced osteoblast function in primary biliary cirrhosis
6. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis
7. Bone disease in liver transplant recipients
8. Bone disease in liver transplant recipients: Incidence, timing, and risk factors
9. 3 treatment
10. Response to 25-hydroxyvitamin D, Bone disease in primary biliary cirrhosis histologic features
11. Low bone turnover state in primary biliary cirrhosis
12. Bone disease in primary biliary cirrhosis: Increased bone resorption and turnover in the absence of osteoporosis or osteomalacia
13. Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis
14. Bone histomorphometric studies in the osteopenia of chronic cholestatic liver disease
15. Long-term calcitonin therapy in postmenopausal osteoporosis
16. Human calcitonin in the management of osteoporosis: A multicentre study
17. Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis
18. Calcitonin and treatment of osteoporosis
19. One-year controlled randomized trial of prevention of early postmenopausal bone loss by intranasal calcitonin
20. Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study
21. Calcitonin for prevention of postmenopausal bone loss
22. Side-effects of synthetic salmon calcitonin given by nitranasal spray compared with intramuscular injection
23. Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women
24. Salmon calcitonin in the treatment of postmenopausal osteoporosis
25. Primary biliary cirrhosis
26. Primary sclerosing cholangitis
27. Simultaneous determination of 26-hydroxy and 1,25 dihydroxyvitamin D from a single sample of dual-cartridge extraction
28. Increase in serum bone y-carboxyglutamic acid protein with aging in women implications for the mechanism of age-related bone loss
29. Modification of a specific assay for hydroxyproline in urine
30. Rapid analysis of amino acids using pre-column derivatization
31. Bone loss after liver transplantation
32. Bone fractures in liver transplant patients
33. Bone loss after orthotopic liver transplantation
34. Bone disease after orthotopic liver transplantation
35. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis
36. Calcitonin and bisphosphonates treatment in bone loss after liver transplantation
37. Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis
38. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
39. Intravenous bisphosphate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation